ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 24937673

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.

Hunter BA and 9 others. Br J Cancer, 2014. Cited by 34 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer. Papers, record 24937673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24937673

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2021-10-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hunter BAB A
2Eustace AA
3Irlam JJJ J
4Valentine HRH R
5Denley HH
6Oguejiofor KKK K
7Swindell RR
8Hoskin PJP J
9Choudhury AA
10West CMC M

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Carcinoma, Transitional CellMajor topic
Hypoxia-Inducible Factor 1, alpha SubunitMajor topic
Urinary Bladder NeoplasmsMajor topic
Aged
Cell Hypoxia
Chemoradiotherapy
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Male
Neoplasm Invasiveness
Proportional Hazards Models
Retrospective Studies
Treatment Outcome

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
C2094/A11365Cancer Research UKUnited KingdomPubMed
G0801525Medical Research CouncilUnited KingdomPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,106,022Reporting recommendations for tumor marker prognostic studies (REMARK).J Natl Cancer Inst2005https://conductscience.org/library/papers/16106022PubMed
27,539,918Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7539918PubMed
322,508,814Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial.J Clin Oncol2012https://conductscience.org/library/papers/22508814PubMed
418,330,514Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.Strahlenther Onkol2008https://conductscience.org/library/papers/18330514PubMed
512,598,309Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.Am J Pathol2003https://conductscience.org/library/papers/12598309PubMed
68,611,159Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin.Biochem J1996https://conductscience.org/library/papers/8611159PubMed
717,574,616An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer.J Urol2007https://conductscience.org/library/papers/17574616PubMed
822,512,481Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.N Engl J Med2012https://conductscience.org/library/papers/22512481PubMed
915,734,974Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.Cancer Epidemiol Biomarkers Prev2005https://conductscience.org/library/papers/15734974PubMed
1012,095,550Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation.Int J Radiat Oncol Biol Phys2002https://conductscience.org/library/papers/12095550PubMed

1 to 10 of 31

See all 31 references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
41,438,430Nanomaterial-Enhanced Immunotherapy: Advancing T-Cell-Based Treatments for Bladder Cancer.Int J Nanomedicine2025https://conductscience.org/library/papers/41438430PubMed
39,031,286The roles of FGFR3 and c-MYC in urothelial bladder cancer.Discov Oncol2024https://conductscience.org/library/papers/39031286PubMed
38,890,455Digital spatial profiling of the microenvironment of muscle invasive bladder cancer.Commun Biol2024https://conductscience.org/library/papers/38890455PubMed
37,240,301Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/37240301PubMed
36,612,036Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36612036PubMed
35,070,817Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database.Transl Androl Urol2021https://conductscience.org/library/papers/35070817PubMed
33,846,523A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.Br J Cancer2021https://conductscience.org/library/papers/33846523PubMed
32,914,000Applying Precision Oncology Principles in Radiation Oncology.JCO Precis Oncol2018https://conductscience.org/library/papers/32914000PubMed
32,264,924ROC-1, P21 and CAIX as markers of tumor aggressiveness in bladder carcinoma in Egyptian patients.Diagn Pathol2020https://conductscience.org/library/papers/32264924PubMed
31,949,844Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma.Int J Clin Exp Pathol2018https://conductscience.org/library/papers/31949844PubMed

1 to 10 of 23

See all 23 cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CA9768PubTator's text mininghttps://conductscience.org/library/genes/768NCBI Gene
HIF1A3,091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
SLC2A16,513PubTator's text mininghttps://conductscience.org/library/genes/6513NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24937673

GET https://conductscience.org/api/papers/v1/24937673/references?page=2

API referenceFor AI assistants